Fetal growth restriction is the second leading cause of perinatal morbidity and mortality, and neonates with intrauterine growth retardation (IUGR) have increased neurocognitive and neuropsychiatric morbidity. These neurocognitive impairments are mainly related to injury of the developing brain associated with IUGR. Growing evidence from preclinical models of brain injury in both adult and neonatal rodents supports the view that nitric oxide can promote neuroprotection
The diffusible messenger, nitric oxide plays multiple roles in neuroprotection, neurodegeneration an...
L’inhalation de monoxyde d’azote (NO) est l’une des thérapies les plus utilisées en réanimation néon...
BackgroundHypoxic–ischemic encephalopathy following perinatal asphyxia is a leading cause of neonata...
Fetal growth restriction is the second leading cause of perinatal morbidity and mortality, and neona...
BACKGROUND: Inhaled nitric oxide (iNO) is one of the most promising therapies used in neonates. Howe...
Several lines of evidence demonstrate that inhaled nitric oxide (iNO) not only acts locally on the p...
BackgroundThere is evidence from various models of hypoxic-ischemic injury (HII) that nitric oxide (...
BackgroundThere is evidence from various models of hypoxic-ischemic injury (HII) that nitric oxide (...
Several lines of evidence demonstrate that inhaled nitric oxide (iNO) not only acts locally on the p...
BACKGROUND AND PURPOSE: Neonates that survive very preterm birth have a high prevalence of cognitive...
BACKGROUND AND PURPOSE: Neonates that survive very preterm birth have a high prevalence of cognitive...
BACKGROUND AND PURPOSE: Neonates that survive very preterm birth have a high prevalence of cognitive...
The diffusible messenger, nitric oxide plays multiple roles in neuroprotection, neurodegeneration an...
Despite advances in neonatal intensive care leading to an increased survival rate in preterm infants...
The diffusible messenger, nitric oxide plays multiple roles in neuroprotection, neurodegeneration an...
The diffusible messenger, nitric oxide plays multiple roles in neuroprotection, neurodegeneration an...
L’inhalation de monoxyde d’azote (NO) est l’une des thérapies les plus utilisées en réanimation néon...
BackgroundHypoxic–ischemic encephalopathy following perinatal asphyxia is a leading cause of neonata...
Fetal growth restriction is the second leading cause of perinatal morbidity and mortality, and neona...
BACKGROUND: Inhaled nitric oxide (iNO) is one of the most promising therapies used in neonates. Howe...
Several lines of evidence demonstrate that inhaled nitric oxide (iNO) not only acts locally on the p...
BackgroundThere is evidence from various models of hypoxic-ischemic injury (HII) that nitric oxide (...
BackgroundThere is evidence from various models of hypoxic-ischemic injury (HII) that nitric oxide (...
Several lines of evidence demonstrate that inhaled nitric oxide (iNO) not only acts locally on the p...
BACKGROUND AND PURPOSE: Neonates that survive very preterm birth have a high prevalence of cognitive...
BACKGROUND AND PURPOSE: Neonates that survive very preterm birth have a high prevalence of cognitive...
BACKGROUND AND PURPOSE: Neonates that survive very preterm birth have a high prevalence of cognitive...
The diffusible messenger, nitric oxide plays multiple roles in neuroprotection, neurodegeneration an...
Despite advances in neonatal intensive care leading to an increased survival rate in preterm infants...
The diffusible messenger, nitric oxide plays multiple roles in neuroprotection, neurodegeneration an...
The diffusible messenger, nitric oxide plays multiple roles in neuroprotection, neurodegeneration an...
L’inhalation de monoxyde d’azote (NO) est l’une des thérapies les plus utilisées en réanimation néon...
BackgroundHypoxic–ischemic encephalopathy following perinatal asphyxia is a leading cause of neonata...